Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa.

Neuroscience letters - 21 Jun 2010

Nishioka Kenya, Vilariño-Güell Carles, Cobb Stephanie A, Kachergus Jennifer M, Ross Owen A, Wider Christian, Gibson Rachel A, Hentati Faycal, Farrer Matthew J

Abstract excerpt

Mutations in the glucocerebrosidase gene (GBA) have recently been associated with an increased risk of Parkinson disease (PD). GBA mutations have been observed to be particularly prevalent in the Ashkenazi Jewish population. Interestingly, this population also has a high incidence of the Lrrk2 p....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arabs
Share to Genetic Predisposition to Disease
Share to Genome-Wide Association Study

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucosylceramidase

Share to Mutation

Share to Parkinson Disease

Share to Risk Factors

Share to Tunisia

Source

Open in PubMed Open full text

Identifiers

PMID: 19945510
DOI: 10.1016/j.neulet.2009.11.066
PMCID: PMC2970621

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19945510-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa.PMID 19945510Read ↗

Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson diseaseSemantic proximity Read ↗

Leucine rich repeat kinase 2 (LRRK2) gly2019ser mutation is absent in a second cohort of nigerian africans with parkinson diseaseSemantic proximity Read ↗

Glucocerebrosidase mutations in a Serbian Parkinson's disease population.Semantic proximity Read ↗

Mutations in the glucocerebrosidase gene confer a risk for Parkinson disease in North Africa.Semantic proximity Read ↗

LRRK2 G2019S in the North African population: a review.Semantic proximity Read ↗

Screening of the glucocerebrosidase (GBA) gene in South Africans of African ancestry with Parkinson's disease.Semantic proximity Read ↗

G2019S Mutation of Leucine-Rich Repeat Kinase 2 Is a Cause of Lewy Body Dementia in Patients With North African Ancestors.Semantic proximity Read ↗

Glucocerebrosidase variant T369M is not a risk factor for Parkinson's disease in Sweden.Semantic proximity Read ↗

African ancestry neurodegeneration risk variant disrupts an intronic branchpoint in GBA1.Semantic proximity Read ↗

Glucocerebrosidase mutations are not found in association with LRRK2 G2019S in subjects with parkinsonism.Semantic proximity Read ↗

Negative screening for 12 rare LRRK2 pathogenic variants in a cohort of Nigerians with Parkinson’s diseaseSemantic proximity Read ↗

Negative screening for 12 rare LRRK2 pathogenic variants in a cohort of Nigerians with Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.